Predictive Oncology Inc.
POAI
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research sā¦ read more
Healthcare
Medical Instruments & Supplies
15 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$6.27
Price-0.56%
-$0.03
1Y
Price
Market Cap
$4.549m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-73839.5%
EBITDA Margin-77256.0%
Net Profit Margin-122939.9%
Free Cash Flow MarginRevenue
$1.070m
-34.1%
1y CAGR-8.2%
3y CAGR-4.7%
5y CAGREarnings
-$9.778m
+19.9%
1y CAGR+26.1%
3y CAGR+11.8%
5y CAGREPS
-$1.45
+35.3%
1y CAGR+40.4%
3y CAGR+31.0%
5y CAGRBook Value
-$1.653m
$3.435m
Assets$5.089m
Liabilities$1.846m
DebtDebt to Assets
53.7%
-0.2x
Debt to EBITDAFree Cash Flow
-$8.621m
+21.5%
1y CAGR+11.7%
3y CAGR+9.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company